Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services

McEwen, Andy; West, Robert
January 2009
BMC Public Health;2009, Vol. 9 Issue 1, p28
Academic Journal
Background: Effective pharmacotherapies are available for smoking cessation but their efficacy is established through randomised controlled trials where the medication is supplied direct to subjects. In health care settings patient access to medicines is often less direct. The process for obtaining supplies of nicotine replacement therapy (NRT) is relatively easy for smokers attending National Health Service (NHS) Stop Smoking Services in the UK, whilst this is not necessarily the case for those wishing to using prescription only medicines (e.g. bupropion and varenicline). This study was a direct comparison of the short-term validated abstinence rates of NRT and bupropion in a clinical setting. Methods: Data were routinely collected from 2626 clients setting a quit date (82% of those registering) with two London NHS Stop Smoking Services that offered behavioural support combined with pharmacotherapy (NRT and bupropion). Results: Contrary to what would be expected from multiple randomised controlled trials, the CO-validated 3-4 week abstinence rate in clients using NRT was higher than for bupropion (42% versus 34%, p = .003). This difference persisted even when controlling for smoking characteristics, demographic variables and treatment variables 1.40 (95% CI = 1.08 - 1.83). Conclusion: Given that the level of behavioural support received by clients on each medication was identical, the most plausible explanation for the difference in effectiveness between NRT and bupropion perhaps lies with how clients of the Stop Smoking Services obtained their medications. Obtaining NRT was relatively easy for clients throughout the study period whilst this was not the case for bupropion. This study suggests that implementation issues and/or self-selection may influence the effectiveness of medications in health care, as opposed to research, settings.


Related Articles

  • Real world evaluation of three models of NHS smoking cessation service in England.  // BMC Research Notes;2012, Vol. 5 Issue 1, p9 

    The article focuses on a study conducted to evaluate the British National Health Service (NHS) smoking cessation service's three models. To describe the structure and outcomes associated with different services, three local service evaluations were carried out at Bournemouth & Poole Teaching...

  • News. Mead, John // Clinical Risk;Mar2002, Vol. 8 Issue 2, p85 

    The article presents news briefs related to healthcare and law in Great Britain. All National Health Service Trusts in Great Britain were required to review arrangements on the safe administration of intrathecal chemotherapy. The recommendations of the 2001 Report of the National Confidential...

  • CORRESPONDENCE. Aveline, Mark; Sutton, Graham C.; Simpson, Roger; Holdstock, G.; Crichton, N.J.; Russell, N.J.; Pantin, C.F.A.; Griffiths, W.A.D.; Gross, M.L.P.; Pearson, R.M.; Sweny, P.; Moorhead, J.F.; Fonseca, V.; Agnew, J.; Dandona, P.; Narayanan, G.; Curtis, David; Zielinski, C.C. // British Medical Journal (Clinical Research Edition);2/16/1985, Vol. 290 Issue 6467, p553 

    Comments on several medical issues in Great Britain. Disadvantages on the privatization of the National Health Service; Relation of chemotherapy on risk factor of leukemia; Association of convulsions with cyclosporin A in renal transplant recipients.

  • Better combo for smokers?  // Drug Topics;9/2/96, Vol. 140 Issue 17, p10 

    Recommends the use of combined nicotine patch with mecamylamine in reducing cigarette habit of smokers. Side effects of mecamylamine as stand-along medication.

  • Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy? Sims, T.H.; Fiore, M.C.; Sims, Tammy Harris; Fiore, Michael C // CNS Drugs;2002, Vol. 16 Issue 10, p653 

    Various forms of nicotine replacement therapy and bupropion have been found to be efficacious and well tolerated for treating patients dependent on tobacco. However, the currently recommended duration of treatment with pharmacotherapy may be insufficient for some smokers to achieve sustained...

  • How to pass the MRCGP written paper. Shah, Rupal // Pulse;10/7/2002, Vol. 62 Issue 38, p70 

    Presents the facts and key references on smoking and health benefits of smoking cessation in Great Britain. Type of questions; Combination of clinical skills, ethical reasoning, consultation skills and knowledge on the structural changes within the National Health Service; Source of information...

  • Key facts to success in smoking cessation. Morris, David // Pulse;10/7/2002, Vol. 62 Issue 38, p73 

    Presents the key facts to success in smoking cessation in Great Britain. Estimation of 1.7 billion pounds on the cost of the National Health Service; Complications of smoking; Risk of lung cancer.

  • Comparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system. Le Lay, K.; Myon, E.; Hill, S.; Riou-Franca, L.; Scott, D.; Sidhu, M.; Dunlop, D.; Launois, R. // European Journal of Health Economics;Jun2007, Vol. 8 Issue 2, p145 

    The National Institute for Health and Clinical Excellence recommends vinorelbine (VNB), paclitaxel, docetaxel, and gemcitabine in the treatment of non-small cell lung cancer. An economic model was prepared to determine the comparative cost of these agents, including the new oral formulation of...

  • MEDICATION WEBSITE FOR YOUNG PEOPLE.  // Healthcare Counselling & Psychotherapy Journal;Jul2014, Vol. 14 Issue 3, p44 

    The article reviews the web site, www.headmeds.org.uk, a website launched by YoungMinds on mental health medication for young people aged between 13 and 25.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics